These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23672712)

  • 1. Estimating unknown parameters in haemophilia using expert judgement elicitation.
    Fischer K; Lewandowski D; Janssen MP
    Haemophilia; 2013 Sep; 19(5):e282-8. PubMed ID: 23672712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials.
    Fischer K; Collins P; Björkman S; Blanchette V; Oh M; Fritsch S; Schroth P; Spotts G; Ewenstein B
    Haemophilia; 2011 May; 17(3):433-8. PubMed ID: 21299740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
    Fischer K; Valentino L; Ljung R; Blanchette V
    Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary prophylaxis treatment versus on-demand treatment for patients with severe haemophilia A: comparisons of cost and outcomes in Taiwan.
    Liou WS; Tu TC; Cheng SN; Chou TY; Lee CF; Lin TK; Chung MI; Cham TM
    Haemophilia; 2011 Jan; 17(1):45-54. PubMed ID: 20722742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels.
    den Uijl IE; Fischer K; Van Der Bom JG; Grobbee DE; Rosendaal FR; Plug I
    Haemophilia; 2011 Jan; 17(1):41-4. PubMed ID: 20825504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilia care in Europe: the ESCHQoL study.
    Schramm W; Gringeri A; Ljung R; Berger K; Crispin A; Bullinger M; Giangrande PL; Von Mackensen S; Mantovani LG; Nemes L; Serban M;
    Haemophilia; 2012 Sep; 18(5):729-37. PubMed ID: 22639833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of children with severe haemophilia A and inhibitors: a health economic evaluation for Germany.
    Berger K; Schopohl D; Eheberg D; Auerswald G; Kurnik K; Schramm W
    Klin Padiatr; 2013 May; 225(3):152-8. PubMed ID: 23519749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between joint bleeds and Pettersson scores in severe haemophilia.
    Fischer K; van Hout BA; van der Bom JG; Grobbee DE; van den Berg HM
    Acta Radiol; 2002 Sep; 43(5):528-32. PubMed ID: 12423465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of joint bleeding before starting prophylaxis in severe haemophilia.
    Nijdam A; Foppen W; van der Schouw YT; Mauser-Bunschoten EP; Schutgens RE; Fischer K
    Haemophilia; 2016 Nov; 22(6):852-858. PubMed ID: 27396935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on-demand therapy in young children with severe haemophilia A.
    Risebrough N; Oh P; Blanchette V; Curtin J; Hitzler J; Feldman BM
    Haemophilia; 2008 Jul; 14(4):743-52. PubMed ID: 18422610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can long-term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands.
    van Dijk K; Fischer K; van der Bom JG; Scheibel E; Ingerslev J; van den Berg HM
    Br J Haematol; 2005 Jul; 130(1):107-12. PubMed ID: 15982352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment.
    Den Uijl I; Mauser-Bunschoten EP; Roosendaal G; Schutgens R; Fischer K
    Haemophilia; 2009 Nov; 15(6):1215-8. PubMed ID: 19686467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the effectiveness and cost-effectiveness of prophylaxis against bleeding in patients with severe haemophilia and severe von Willebrand's disease.
    Miners AH; Sabin CA; Tolley KH; Lee CA
    J Intern Med; 1998 Dec; 244(6):515-22. PubMed ID: 9893105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life.
    Khawaji M; Astermark J; Berntorp E
    Eur J Haematol; 2012 Apr; 88(4):329-35. PubMed ID: 22221195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of joint damage in hemophilic children with early prophylaxis.
    Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
    Orthopade; 1999 Apr; 28(4):341-346. PubMed ID: 28246905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients. A randomised, active-controlled, double-blind study.
    Powell J; Martinowitz U; Windyga J; Di Minno G; Hellmann A; Pabinger I; Maas Enriquez M; Schwartz L; Ingerslev J;
    Thromb Haemost; 2012 Nov; 108(5):913-22. PubMed ID: 23014711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of bleeding in haemophilia: is one bleed too many?
    Gringeri A; Ewenstein B; Reininger A
    Haemophilia; 2014 Jul; 20(4):459-63. PubMed ID: 24472015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term low-dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi-centre pilot study in China.
    Tang L; Wu R; Sun J; Zhang X; Feng X; Zhang X; Luke KH; Poon MC
    Haemophilia; 2013 Jan; 19(1):27-34. PubMed ID: 23231016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.